Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
135.25B
Market cap135.25B
Price-Earnings ratio
47.10
Price-Earnings ratio47.10
Dividend yield
Dividend yield
Average volume
12.74M
Average volume12.74M
High today
$93.00
High today$93.00
Low today
$87.03
Low today$87.03
Open price
$88.21
Open price$88.21
Volume
20.61M
Volume20.61M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

With a market cap of 135.25B, Boston Scientific(BSX) trades at $91.87. The stock has a price-to-earnings ratio of 47.10.

During the trading session on 2026-01-21, Boston Scientific(BSX) shares reached a daily high of $93.00 and a low of $87.03. At a current price of $91.87, the stock is +5.6% higher than the low and still -1.2% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 20.61M, versus its average volume of 12.74M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

Simply Wall St 5h
Boston Scientific’s Big Bets On Growth Versus Valuation In Focus

Boston Scientific (NYSE:BSX) announced a $14.5b agreement to acquire Penumbra, expanding into neurovascular and mechanical thrombectomy markets. The company al...

Boston Scientific’s Big Bets On Growth Versus Valuation In Focus
TipRanks 15h
Boston Scientific Advances CHORUS IDx: New Imaging Study Targets Smarter Atrial Ablation

Boston Scientific (BSX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview Boston Scientific is launching a f...

TipRanks 22h
Penumbra downgraded to Hold from Buy at Canaccord

Canaccord downgraded Penumbra (PEN) to Hold from Buy with a price target of $374, up from $359. The firm cites Boston Scientific’s (BSX) agreement to acquire Pe...

Analyst ratings

95%

of 37 ratings
Buy
94.6%
Hold
5.4%
Sell
0%

More BSX News

Simply Wall St 4d
Assessing Boston Scientific Valuation After Recent Share Price Weakness

Advertisement What recent performance says about Boston Scientific (BSX) Boston Scientific (BSX) has been under pressure lately, with the stock showing a 2.2%...

Assessing Boston Scientific Valuation After Recent Share Price Weakness
TipRanks 5d
Boston Scientific to Acquire Penumbra in Cash-Stock Merger

Claim 70% Off TipRanks Premium Boston Scientific ( (BSX) ) has issued an update. On January 14, 2026, Boston Scientific entered into a definitive agreement to...

Nasdaq 6d
S&P 500 Movers: BSX, AMCR

In early trading on Thursday, shares of Amcor topped the list of the day's best performing components of the S&P 500 index, trading up 399.1%. Year to date, Amc...

S&P 500 Movers: BSX, AMCR
TipRanks 6d
M&A News: Penumbra Stock Beats Harder on $14.5B Boston Scientific Acquisition

Shares in medical devices business Penumbra (PEN) rocketed 13% in pre-market trading today after it was bought by peer Boston Scientific (BSX) for $14.5 billion...

Benzinga 6d
Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy

Boston Scientific Corporation (NYSE:BSX) stock fell Thursday, while Penumbra, Inc. (NYSE:PEN) climbed, following news that the medical device giant agreed to ac...

Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy
Nasdaq 6d
BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies

Boston Scientific, Inc. BSX recently announced that it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held fi...

BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies
MarketWatch 6d
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

Penumbra, which developed the Lightning Bolt 6X, to remove blood clots below the knee, is now being acquired by Boston Scientific. Boston Scientific is spendin...

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .